Oncolytic vaccinia virus: from bedside to benchtop and back

Virus combinations and chemotherapy for the treatment of human cancers

Oncolytic virotherapy as a personalized cancer vaccine

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]

TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis